Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 3016-3023

  Schrag, Stephanie J ^a,e   McGee, Lesley ^a,b   Whitney, Cynthia G ^a   Beall, Bernard ^a   Craig, Allen S ^c   Choate, Miriam E ^b   Jorgensen, James H ^d   Facklam, Richard R ^a   Klugman, Keith P ^a,b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c TENNESSEE DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MEROPENEM; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

AGE DISTRIBUTION; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL VARIATION; DRUG SENSITIVITY; EPIDEMIC; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION; POPULATION SURVEILLANCE; RISK FACTORS; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC); STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 3342939866     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.3016-3023.2004     Document Type: Article

References (31)

1. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
2. Butler, J. C., J. Hofmann, M. S. Cetron, J. A. Elliott, R. R. Facklam, R. F. Breiman, et al. 1996. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J. Infect. Dis. 174:986-993.
3. Chen, D. K., A. McGeer, J. C. de Azavedo, D. E. Low, and the Canadian Bacterial Surveillance Network. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239.
4. Coffey, T. J., M. Daniels, L. K. McDougal, C. G. Dowson, F. C. Tenover, and B. G. Spratt. 1995. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 39:1306-1313.
5. Dagan, R., O. Abramson, E. Leibovitz, R. Lang, S. Goshen, D. Greenberg, P. Yagupsky, A. Leiberman, and D. M. Fliss. 1996. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr. Infect. Dis. J. 15:980-985.
6. Dagan, R., E. Leibovitz, A. Leiberman, and P. Yagupsky. 2000. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr. Infect. Dis. J. 19:S57-S65.
7. Doit, C., C. Loukil, F. Fitoussi, P. Geslin, and E. Bingen. 1999. Emergence in France of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin. Antimicrob. Agents Chemother. 4:1480-1483.
8. Dowell, S. F., J. C. Butler, G. S. Giebink, M. R. Jacobs, D. Jernigan, D. M. Musher, A. Rakowsky, and B. Schwartz. 1999. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr. Infect. Dis. J. 18:1-9.
9. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
10. Feikin, D. R., A. Schuchat, M. Kolczak, J. Hadler, L. H. Harrison, L. Lefkowitz, et al. 2000. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am. J. Public Health 90:223-229.
11. Gertz, R. J., M. MeEllistrem, D. Boxrud, Z. Li, V. Sakota, T. Thompson, R. Facklam, J. Besser, L. Harrison, C. Whitney, and B. Beall. 2003. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J. Clin. Microbiol. 41:4194-4216.
12. Hall, L. M., R. A. Whiley, B. Duke, R. C. George, and A. Efstratiou. 1996. Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J. Clin. Microbiol. 34:853-859.
13. Huebner, R. E., A. D. Wasas, and K. P. Klugman. 2000. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. Int. J. Infect. Dis. 4:214-218.
14. Jacobs, M., H. Koornhof, R. Robins-Browne, C. Stevenson, Z. Vermaak, I. Freiman, G. Miller, M. Witcomb, M. Isaacson, J. Ward, and R. Austrian. 1978. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299:735-740.
15. Kaplan, S. L., and E. O. Mason. 1998. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. Rev. 11:628-644.
16. Kaplan, S. L., E. O. Mason, W. J. Barson, T. Q. Tan, G. E. Schutze, H. S. Bradley, L. B. Givner, K. S. Kim, R. Yogev, and E. R. Wald. 2001. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics. Pediatr. Infect. Dis. J. 20:392-396.
17. Karlowsky, J. A., M. E. Jones, D. C. Draghi, and D. F. Sahm. 2003. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Antimicrob. Agents Chemother. 47:3155-3160.
18. Klugman, K., H. Koornhof, and I. Friedland. 1992. Antibiotic resistance in pneumococcal meningitis. Lancet 340:437-438.
19. Lefevre, J. C., G. Faucon, A. M. Sicard, and A. M. Gasc. 1993. DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis. J. Clin. Microbiol. 31:2724-2728.
20. Maisnier-Patin, S., O. G. Berg, L. Liljas, and D. I. Andersson. 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol. Microbiol. 46:355-366.
21. MeDougal, L. K., J. K. Rasheed, J. W. Biddle, and F. C. Tenover. 1995. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob. Agents Chemother. 39:2282-2288.
22. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefevre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
23. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing. Thirteenth informational supplement, M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Nilsson, A. I., O. G. Berg, O. Aspevall, G. Kahlmeter, and D. I. Andersson. 2003. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob. Agents Chemother. 47:2850-2858.
25. Pallares, R., O. Capdevila, J. Linares, I. Grau, H. Onaga, F. Tubau, M. H. Schulze, P. Hohl, and F. Gudiol. 2002. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am. J. Med. 113:120-126.
26. Schrag, S. J., V. Perrot, and B. R. Levin. 1997. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. Lond. B Biol. Sci. 264:1287-1291.
27. Simberkoff, M. S., M. Lukaszewski, A. Cross, M. Al-Ibrahim, A. L. Baltch, R. P. Smith, P. J. Geiseler, J. Nadler, and A. S. Richmond. 1986. Antibiotic-resistant isolates of Streptococcus pneumoniae from clinical specimens: a cluster of serotype 19A organisms in Brooklyn, New York. J. Infect. Dis. 153:78-82.
28. Smith, A. M., and K. P. Klugman. 2000. Non-penicillin-binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae. Microb. Drug Resist. 6:105-110.
29. Spika, J. S., R. R. Facklam, B. D. Plikaytis, M. J. Oxtoby, and the Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect. Dis. 163:1273-1278.
30. Turrett, G. S., S. Blum, B. A. Fazal, J. E. Justman, and E. E. Telzak. 1999. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence. Clin. Infect. Dis. 29:321-327.
31. Whitney, C., M. Farley, J. Hadler, L. Harrison, C. Lexau, A. Reingold, L. Lefkowitz, P. Cieslak, M. Cetron, E. Zell, J. Jorgensen, and A. Schuchat. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:1917-1924.